Controlled modulation of LAT activity either through altered phosphorylation of LAT [45], or by amino acid substitution in the sequence of LAT [46], has been considered as a potential strategy to enhance the efficacy of adoptive immunotherapy in cancer using chimeric antigen receptor or CAR T-cells [47]. Here, LAT is linked to cancer.